Showing results (71-80 of 198) with videos related to

Sort By:
Pageof 20
Circulation Journal : Official Journal of the Japanese Circulation Society|February 19, 2016
Edoxaban vs. Warfarin in East Asian Patients With Atrial Fibrillation - An ENGAGE AF-TIMI 48 SubanalysisTakeshi Yamashita, Yukihiro Koretsune, Yuejin Yang, et al.
European Journal of Heart Failure|June 29, 2016
Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: insights from ENGAGE AF-TIMI 48Giulia Magnani, Robert P Giugliano, Christian T Ruff, et al.
The American Journal of Medicine|March 21, 2016
Mortality in Patients with Atrial Fibrillation Randomized to Edoxaban or Warfarin: Insights from the ENGAGE AF-TIMI 48 TrialRobert P Giugliano, Christian T Ruff, Stephen D Wiviott, et al.
European Heart Journal|April 28, 2025
ApoB-containing lipoproteins: count, type, size, and risk of coronary artery diseaseJakub Morze, Giorgio E M Melloni, Clemens Wittenbecher, et al.
American Heart Journal|October 12, 2010
Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48)Christian T Ruff, Robert P Giugliano, Elliott M Antman, et al.
European Heart Journal. Acute Cardiovascular Care|July 25, 2018
Edoxaban in atrial fibrillation patients with established coronary artery disease: Insights from ENGAGE AF-TIMI 48Thomas A Zelniker, Christian T Ruff, Stephen D Wiviott, et al.
American Heart Journal|January 6, 2022
Edoxaban versus Warfarin in high-risk patients with atrial fibrillation: A comprehensive analysis of high-risk subgroupsBaris Gencer, Alon Eisen, David Berger, et al.
Circulation. Cardiovascular Quality and Outcomes|May 12, 2018
Gastrointestinal Bleeding With Edoxaban Versus Warfarin: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis In Myocardial Infarction)James Aisenberg, Prapti Chatterjee-Murphy, Kathryn Friedman Flack, et al.
International Journal of Cardiology|February 4, 2020
Efficacy and safety of edoxaban in patients with diabetes mellitus in the ENGAGE AF-TIMI 48 trialAnna Plitt, Christian T Ruff, Assen Goudev, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 22, 2018
Edoxaban and implantable cardiac device interventions: insights from the ENGAGE AF-TIMI 48 trialJan Steffel, Christian T Ruff, Eugene Braunwald, et al.
Pageof 20